Skip to main content

Drug Recalls News

News
Teva Pharmaceuticals USA is recalling two lots of extended-release methylphenidate hydrochloride tablets because product bottles may not contain desiccants, according to the February 19, 2020, US Food and Drug Administration (FDA) Enforcement Report. The recall affects the following products,…
News
After a customer reportedly found a nylon cable tie in a bottle, AuroMedics Pharma issued a recall for a single lot of amoxicillin and clavulanate potassium tablets. The recall was included in the February 19, 2020, US Food and Drug Administration (FDA) Enforcement Report.  The recall affects…
News
Citing defective bottles that may not seal appropriately and protect from moisture, Pfizer Inc. is recalling two lots of Caduet (amlodipine besylate/atorvastatin calcium) tablets. The recall was announced in the February 19, 2020, US Food and Drug Administration (FDA) Enforcement Report.  The…
News
Taro Pharmaceuticals USA Inc. is recalling a single lot of 100-mg lamotrigine tablets in 100-count bottles (NDC 51672-4131-1) because of cross-contamination with the drug enalapril maleate, which was manufactured at the same facility. According to the February 19, 2020, US Food and Drug…
News
Teva Pharmaceuticals USA is recalling several lots of desmopressin acetate tablets over concerns product bottles may not contain desiccants. The recall is included in the February 12, 2020, US Food and Drug Administration (FDA) Enforcement Report.  The recall affects the following products: …
News
Ascend Laboratories is pulling 4728 bottles of minocycline hydrochloride extended-release tablets because samples failed to meet dissolution specifications during routine testing, according to the February 12, 2020, US Food and Drug Administration (FDA) Enforcement Report.  The recall affects 30-…
News
Nearly 30,000 bottles of 10-mg atorvastatin calcium tablets are being recalled by Graviti Pharmaceuticals after a customer reported finding a 20-mg tablet in a bottle, according to the  February 12, 2020, US Food and Drug Administration (FDA) Enforcement Report.  The recall includes 90-count…
News
Mylan Pharmaceuticals Inc. is recalling more than 48,000 bottles of nizatidine capsules after trace amounts of the probable human carcinogen N-Nitrosodimethylamine (NDMA) were detected in the medication, according to the January 29, 2020, US Food and Drug Administration (FDA) Enforcement Report.…
News
New ranitidine recalls prompted by suspected product contamination with the probable human carcinogen N-Nitrosodimethylamine (NDMA) have been announced by four firms. The latest recalls were included in the January 29, 2020, US Food and Drug Administration (FDA) Enforcement Report.  On December 11…
News
Sun Pharmaceutical Industries Inc. has recalled multiple drugs this week*. First the firm is recalling sumatriptan succinate tablets in bottles and blister packs after medication samples failed to meet impurity/degradation specifications during routine testing, according to the January 22, 2020, US…
Back to Top